| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| rituximab bendamustine macmillan | 1.55 | 0.2 | 2680 | 94 | 32 |
| rituximab | 1.51 | 0.3 | 3899 | 20 | 9 |
| bendamustine | 1.39 | 0.2 | 2812 | 55 | 12 |
| macmillan | 0.02 | 0.5 | 2841 | 84 | 9 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| rituximab bendamustine macmillan | 0.57 | 0.7 | 5446 | 11 |
| bendamustine and rituximab macmillan | 0.37 | 0.2 | 8262 | 92 |
| polatuzumab bendamustine rituximab macmillan | 1.22 | 0.5 | 4460 | 23 |
| rituximab and bendamustine regimen | 1.41 | 0.3 | 9932 | 28 |
| rituximab and bendamustine treatment | 1.64 | 0.1 | 9875 | 28 |
| bendamustine and rituximab protocol | 1.55 | 0.6 | 1644 | 70 |
| bendamustine and rituximab for cll | 0.27 | 0.5 | 921 | 8 |
| bendamustine and rituximab for lymphoma | 1.06 | 0.6 | 7854 | 29 |
| bendamustine and rituxan regimen | 0.58 | 0.5 | 8183 | 68 |
| rituxan and bendamustine treatment | 1.56 | 1 | 623 | 80 |
| side effects of rituximab and bendamustine | 1.13 | 0.9 | 4705 | 11 |
| bendamustine and rituxan for lymphoma | 0.02 | 0.9 | 9634 | 74 |
| fiche patient rituximab bendamustine | 1.49 | 0.2 | 1377 | 22 |
| bendamustine rituximab follicular lymphoma | 0.75 | 1 | 1134 | 59 |
| bendamustine rituximab mantle cell lymphoma | 0.3 | 0.4 | 3922 | 76 |
| bendamustine rituximab waldenstrom protocol | 0.02 | 0.1 | 2300 | 1 |
| rituximab polatuzumab bendamustine protocol | 1.12 | 0.5 | 732 | 88 |
| nssg bendamustine and rituximab | 1.61 | 0.1 | 6751 | 39 |
| bendamustina y rituximab efectos secundarios | 0.06 | 0.9 | 8503 | 68 |
